Skip to content

Fast Company recognizes Rapid Aortic in its 2026 Innovation by Design Awards

Learn more
  • There are no suggestions because the search field is empty.
Request a Demo
Request a Demo

Core Capabilities

Overview

Clinical-AI-portfolio
BLOG The Rapid Enterprise™ Platform The only enterprise platform connecting imaging to clinical action across the health system LEARN MORE
Platform overview
Request a Demo

RADIOLOGY SUPPORT

Neurovascular

Cardiac + vascular

LIFE SCIENCES

Featured

Cognitive Burden index RapidAI 2025
BLOG Radiology’s real challenge Read about the reality of cognitive burden LEARN MORE
Solutions overview
Request a Demo

BUILT TO SUPPORT THE FULL SYSTEM

FEATURED

Resource_1600x900_C-Suite-Exec Insights_white paper
WHITE PAPER Empowering healthcare leaders with a deep clinical AI enterprise platform Learn how AI can address real-world challenges for administrators LEARN MORE
Overview
Request a Demo

Core Capabilities

Featured

Radiology Rewired podcast
PODCAST Season 1 available now Exploring how AI is transforming Radiology—one conversation at a time with clinicians and innovators LEARN MORE
Overview
Request a Demo

TRAINING & LEARNING

HELP & ASSISTANCE

Overview
Request a Demo

LEARN MORE ABOUT RAPIDAI

WORK WITH US

FEATURED

video thumbnail for dr Gregory Albers
VIDEO The story behind RapidAI Hear our founder, Greg Albers, MD, tell the history of how the company came to be Watch now
Company overview
Request a Demo
featured-image

Partner press release

AZmed Connects X-ray AI Findings to Coordinated Care Through RapidAI

PARIS, October 27, 2026 — AZmed, one of the leading AI companies in medical imaging, today announced that its FDA-cleared AZtrauma and AZchest X-ray AI applications are available through RapidAI, a global leader in enterprise clinical AI, via the Rapid Enterprise Platform. The applications join a portfolio of 50+ clinical solutions that support radiologists and care teams across the patient journey, bringing AZmed’s X-ray analysis capabilities into a connected platform used by more than 2,500 hospitals. X-ray findings can shape urgent decisions about treatment and follow-up, making timely interpretation and communication essential. AI can help radiologists identify suspected abnormalities and prioritize exams for review, while a shared clinical platform makes those insights accessible to the care teams acting on them. This connects support for the radiologist’s read with the coordination needed for next steps in care. In the U.S., AZtrauma detects fractures, joint effusions and dislocations on musculoskeletal X-rays across adult and pediatric (ages ≥ 2) populations. AZchest covers five findings on frontal chest X-rays: lung nodules, consolidation, pneumothorax, pleural effusion and increased cardiothoracic ratio, with triage and notification for pneumothorax and pleural effusion. The integration gives teams a consistent way to access and act on AI findings across clinical specialties, reducing the need to navigate separate AI tools. Radiologists receive AZmed results and worklist prioritization through Rapid Navigator Pro, while emergency physicians and orthopedic teams access results through the Rapid Mobile App, giving them shared clinical context to coordinate next steps. For health systems, a single IT deployment simplifies adding and managing AZmed’s applications alongside RapidAI solutions. Rapid Edge Cloud provides resilient infrastructure, while Rapid Insights gives health systems centralized visibility into AI program utilization and performance to support oversight as they expand their use of clinical AI. “AZtrauma and AZchest are built to fit the way a radiology department already works, not to add another screen to it,” said Julien VIDAL, CEO of AZmed. “Through the Rapid Enterprise Platform, radiologists read with our results in the same place as the rest of their AI, and the emergency and orthopedic teams act on those same findings.” The collaboration advances AZmed’s expansion in the U.S., making its FDA-cleared X-ray AI available to health systems through RapidAI’s established clinical network.
featured-image

Partner press release

Optellum and RapidAI Bring AI-Supported Lung Nodule Management to the Rapid Enterprise™ Platform

OXFORD, United Kingdom and HOUSTON, October 20, 2026 — Optellum, the leader in AI-enabled lung cancer diagnostics, today announced that its Virtual Nodule Clinic (VNC) with Lung Cancer Prediction (LCP) AI is integrated with the Rapid Enterprise™ Platform from RapidAI, a global leader in enterprise clinical AI. VNC joins a portfolio of 50+ RapidAI-developed and third-party clinical solutions that support radiologists and care teams across the patient journey, extending the platform's oncology coverage to the lung nodule pathway. RapidAI technology is used in more than 2,500 hospitals across 100+ countries. Lung cancer remains the leading cause of cancer death in the United States and worldwide.1 Many lung nodules are found incidentally on CT scans performed for other reasons, and 60% are lost to follow-up2. Without a clear path to follow-up, the opportunity for earlier diagnosis can be missed. Optellum VNC includes Patient Discovery AI, which automatically searches radiology reports for documented lung nodules and identifies patients for review. VNC’s workflow management tools support patient tracking and follow-up, and LCP AI analyzes CT images to assess a nodule's cancer risk. Together, these capabilities help care teams prioritize patients and reduce the risk of patients being lost to follow-up. VNC with LCP AI is the world's first FDA-cleared and Medicare-reimbursed AI solution for image-based lung cancer risk stratification, reimbursed under named CPT 0721T/+0722T. Optellum is directly deployed at hundreds of clinical sites and has analyzed over 3 million cases to date. Integration with the Rapid Enterprise Platform will help accelerate that footprint, bringing Optellum’s capabilities to more care teams. Through the integration, pulmonologists and clinic managers can access Optellum's capabilities as part of a connected enterprise platform. Health systems can deploy Optellum on their existing RapidAI platform through a single IT deployment, supported by consistent clinical workflows, best-in-class clinical solutions, and shared AI governance capabilities that provide a central place to monitor performance and oversee AI use. "Our collaboration with RapidAI makes Virtual Nodule Clinic available to the many health systems that already rely on the Rapid Enterprise Platform," said Johnathan Watkins, PhD, CEO of Optellum. "Integrating VNC into the Rapid platform expands access, streamlines IT deployment, and accelerates putting clinically validated solutions in the hands of care teams. Together, we can help more patients with lung nodules get the right care sooner." The solutions support clinical decision-making, with qualified clinicians responsible for interpreting results and determining appropriate patient care.
featured-image

Partner press release

Riverain Technologies Expands Access to ClearRead™ Advanced Chest Imaging AI Through RapidAI's Enterprise Platform

MIAMISBURG , Ohio, October 6, 2026 — Riverain Technologies, a leader in cardiothoracic imaging AI, today announced that its FDA-cleared ClearRead™ Chest suite will be available through RapidAI, a global leader in enterprise clinical AI, via its Rapid Enterprise™ Platform. The integration expands access to Riverain's advanced lung and cardiac imaging intelligence within RapidAI's connected enterprise platform, helping radiologists identify subtle findings, reduce cognitive burden, and move from imaging insight to clinical action with less workflow friction. Designed for chest CTs and X-rays, ClearRead Chest is a cardiothoracic AI suite that helps radiologists detect, characterize and visualize pulmonary nodules, pneumothoraces, and coronary artery calcification (CAC). Riverain's patented vessel and bone suppression technology provides an unobstructed view of the lungs to improve visualization of nodules and other pathology. The ClearRead Chest suite delivers clinically proven accuracy and time-saving insights within radiologists' existing workflows, helping ease cognitive burden and support more confident decisions. Riverain develops clinically validated cardiothoracic imaging technology designed to help radiologists see, detect, characterize, and report subtle findings more clearly. Integrating ClearRead Chest into RapidAI's connected platform extends the technology into an enterprise environment that unifies imaging intelligence, clinical workflows, and patient management, helping health systems scale AI without adding separate systems or operational complexity. ClearRead Chest integrates into the Enterprise Platform, including its Rapid Edge Cloud™ infrastructure, the Rapid Navigator Pro™ radiology workflow solution, RapidAI's mobile and web applications, and its AI governance capabilities. The integration will create a secure, interoperable experience across PACS, EHR, and reporting systems, allowing health systems to deploy Riverain's cardiothoracic imaging intelligence while maintaining workflow consistency and enterprise-grade infrastructure. “ClearRead was developed to help radiologists see subtle chest findings more clearly and confidently within the workflows they already rely on every day,” said Steve Worrell, CEO of Riverain Technologies. “By integrating ClearRead Chest into the Rapid Enterprise Platform, we’re expanding access to our advanced chest imaging technology to support earlier detection of leading global killers like lung cancer, and cardiovascular disease and reduce the burden on radiologists facing increasingly complex imaging workloads.” Through the integration, Riverain's ClearRead Chest suite will be available to RapidAI's install base of more than 2,500 hospitals. The collaboration gives Riverain a broader path to scale advanced cardiothoracic imaging intelligence across health systems while allowing customers to access Riverain and RapidAI solutions through one connected workflow. For Riverain, the collaboration advances its mission to reduce delayed cardiothoracic diagnoses by bringing ClearRead Chest to more radiologists within the systems they use every day. For RapidAI, the integration expands its enterprise imaging ecosystem with clinically validated third-party AI for lung and cardiovascular disease, building on its full-body portfolio.
featured-image

Customer press release

OSF HealthCare expands use of RapidAI among all hospitals

PEORIA, Ill., Aug. 10, 2026 — OSF HealthCare, a not-for-profit health system serving communities across Illinois and Michigan, and technology vendor RapidAI, a global leader in enterprise clinical AI, today announced the expansion of the Rapid Enterprise™ Platform to all 18 hospitals in the OSF Ministry. Building on an initial deployment at select sites, the expansion will give each OSF hospital access to an advanced platform built to analyze medical images, connect care teams, and support patient management across the patient journey. RapidAI’s deep clinical AI goes beyond alerting teams to a potential finding. It provides automated measurements, disease characterization, and advanced visualization, giving radiologists and clinicians a clearer, more complete picture of each patient’s condition. By automating parts of image analysis and delivering actionable clinical context, the platform helps OSF teams apply their expertise where it matters most, to make informed decisions and coordinate next steps. Keeping that information connected as patients move through the system helps reduce fragmentation and maintain continuity across the network. OSF expanded its use of the RapidAI platform after seeing measurable improvements in treatment times and more consistent identification of people who might have suffered a stroke and required intervention. The expansion builds on those results with a technology provider focused on deeper integration, enterprise governance, analytics, and ongoing optimization across its hospitals. “Every community we serve should benefit from the same advanced technology, whether a patient enters one of our largest medical centers or a rural, critical access hospital,” said Arun Talkad, MD, a neurologist who directs stroke care at OSF HealthCare. “After seeing how RapidAI supported clinical decisions and patient care at select sites, we saw the opportunity to add more AI solutions to the platform and extend that value across all hospitals, strengthening access to specialty expertise and helping us deliver high-quality, consistent care at every level of our health system.” The Rapid Enterprise Platform is designed to support health systems beyond a single disease state or moment in care. RapidAI’s clinical coverage spans neuro, cardiac and vascular care, trauma, and oncology. It combines deep clinical AI with advanced 3D visualization across the body, care coordination, enterprise analytics and longitudinal patient management. RapidAI- developed and curated third-party applications allow health systems to scale AI across specialties and follow disease over time through one platform. OSF is committed to ensuring reliable care at all times. The platform's infrastructure, Rapid Edge Cloud, is designed to keep critical decision support and care coordination tools available even during a network or cloud outage, helping minimize disruption and keep care consistently available. “Our goal is to help hospitals deliver the best possible care for the communities they serve, and validated AI that improves clinical decision-making can be a powerful part of that,” said Karim Karti, CEO of RapidAI. “OSF is leading by example, implementing AI across its enterprise to help teams work at their best, reduce variation and make informed decisions. We are proud to support that vision as its strategic enterprise AI partner.” The expansion builds on recognized leadership at OSF HealthCare in using technology to strengthen patient care. In 2025, Fortune named OSF one of America’s Most Innovative Companies for the second time, making it the only Illinois health system on the list. OSF also earned CHIME Digital Health Most Wired recognition for the 14th consecutive year, achieving Level 9 certification across acute, ambulatory and long-term acute care settings. These honors reinforce OSF is a leader in applying technology at scale to improve care.
featured-image

Press Release

RapidAI Highlights Research Depth and Industry Leadership at ISC 2026 With 28 Clinical Abstracts

SAN MATEO, CA (February 4, 2026) - RapidAI, the pioneer of deep clinical AI and global leader in enterprise imaging, today announced details of 28 scientific abstracts accepted at the International Stroke Conference (ISC) 2026, held February 4-6, at the Ernest N. Morial Convention Center in New Orleans. The abstracts span aneurysm monitoring, ischemic stroke detection, advanced imaging visualization, and radiology workflow optimization. Findings reflect the impact of deep clinical AI delivered through the Rapid Enterprise™ platform, designed to scale across radiology and acute workflows. The clinical data demonstrate how RapidAI’s clinically validated, FDA-cleared AI solutions can improve diagnostic performance, reduce interpretation time, and deliver measurable efficiency and economic gains for stroke teams and radiology departments. Rapid’s unique approach, called Deep Clinical AI, delivers real results by providing not just triage notifications but also visualization, localization, characterization, and tracking changes over time. The following abstracts highlight this approach and will be presented at the time below during ISC. Additional RapidAI abstract descriptions accepted by ISC can be found here.
featured-image

Press Release

RapidAI and AWS Strengthen Relationship: Accelerate Global Deployment of Deep Clinical AI

CHICAGO — December 1, 2025 — RapidAI, the pioneer of deep clinical AI and global leader in enterprise imaging, and Amazon Web Services (AWS), today announced a strengthened working relationship to accelerate the global adoption and scalability of deep clinical AI in healthcare. The companies will focus on co-development and go-to-market alignment, bringing together AWS’s AI infrastructure and machine learning pipelines with RapidAI’s deep clinical expertise and multimodal healthcare data.
featured-image

Press Release

RapidAI Extends the Reach of Deep Clinical AI with Five New FDA Clearances

SAN MATEO, Calif. — November 25, 2025 — RapidAI, the pioneer of deep clinical AI and global leader in enterprise imaging, today announced the U.S. Food and Drug Administration (FDA) clearance of five new imaging modules: Rapid DeltaFuse™, Rapid LMVO, Rapid MLS, Rapid OH, and Rapid Aortic for measurement. Together, these clearances mark a significant expansion of the Rapid Enterprise™ Platform, reinforcing RapidAI’s identity as the only platform purpose-built to bring deep clinical intelligence, seamless workflow integration, and secure IT infrastructure to hospitals worldwide.
featured-image

Press Release

RapidAI Earns FDA Clearance for Rapid Aortic, Bringing AI-Driven Aortic Measurements and Surveillance to Care Teams

SAN MATEO, Calif. — November 18, 2025 — RapidAI, the pioneer of deep clinical AI and global leader in enterprise imaging, today announced U.S. Food and Drug Administration (FDA) clearance of Aortic Management, part of the Rapid Aortic product, a comprehensive deep clinical AI solution designed to transform the acute assessment and longitudinal management of aortic disease.
featured-image

Press Release

RapidAI and Health Holdings Company Partner to Bring Deep Clinical AI To Saudi Arabia

San Mateo, Calif. and Riyadh, Saudi Arabia — November 11, 2025 — RapidAI, the pioneer of Deep Clinical AI and global leader in intelligent imaging and workflow integration, today announced a strategic partnership and co-development with Saudi Health Holdings Company (HHC), the largest healthcare provider in the Middle East. Through this collaboration, RapidAI will serve as HHC’s enterprise provider of deep clinical AI across its 20 health clusters network of hospitals and clinics, supporting multiple disease states in neurology, cardiology, vascular, oncology, orthopedic and beyond.
1 2 3